Esther E. Dupont-Versteegden

Esther E. Dupont-Versteegden

Auto-generated profile, based on publicly available information

Esther E. Dupont-Versteegden

Department of Physical Therapy, College of Health Sciences, University of Kentucky, Lexington, KY

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
BFBrian S. Finlin
Brian S. Finlin
HMHasiyet Memetimin
Hasiyet Memetimin
BZBeibei Zhu
Beibei Zhu
ACAmy L. Confides
Amy L. Confides
Hemendra J VekariaHemendra J Vekaria
Hemendra J Vekaria
PKPhilip A Kern
Philip A Kern
BACKGROUND. Beige adipose tissue is associated with improved glucose homeostasis in mice. Adipose tissue contains β3-adrenergic receptors (β3-ARs), and this study was intended to determine whether the treatment of obese, insulin-resistant humans with the β3-AR agonist mirabegron, which stimulates beige adipose formation in subcutaneous white adipose tissue (SC WAT), would induce other beneficial changes in fat and muscle and improve metabolic homeostasis. METHODS. Before and after β3-AR agonist treatment, oral glucose tolerance tests and euglycemic clamps were performed, and histochemical analysis and gene expression profiling were performed on fat and muscle biopsies. PET-CT scans quantified brown adipose tissue volume and activity, and we conducted in vitro studies with primary cultures of differentiated human adipocytes and muscle. RESULTS. The clinical effects of mirabegron treatment included improved oral glucose tolerance (P < 0.01), reduced hemoglobin A1c levels (P = 0.01), and improved insulin sensitivity (P = 0.03) and β cell function (P = 0.01). In SC WAT, mirabegron treatment stimulated lipolysis, reduced fibrotic gene expression, and increased alternatively activated macrophages. Subjects with the most SC WAT beiging showed the greatest improvement in β cell function. In skeletal muscle, mirabegron reduced triglycerides, increased the expression of PPARγ coactivator 1 α (PGC1A) (P < 0.05), and increased type I fibers (P < 0.01). Conditioned media from adipocytes treated with mirabegron stimulated muscle fiber PGC1A expression in vitro (P < 0.001). CONCLUSION. Mirabegron treatment substantially improved multiple measures of glucose homeostasis in obese, insulin-resistant humans. Since β cells and skeletal muscle do not express β3-ARs, these data suggest that the beiging of SC WAT by mirabegron reduces adipose tissue dysfunction, which enhances muscle oxidative capacity and improves β cell function. TRIAL REGISTRATION. Clinicaltrials.gov NCT02919176. FUNDING. NIH: DK112282, P30GM127211, DK 71349, and Clinical and Translational science Awards (CTSA) grant UL1TR001998.

15 October 2012 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
JJJanna R. Jackson
Janna R. Jackson
JMJyothi Mula
Jyothi Mula
TKTyler Kirby
Tyler Kirby
CFChristopher S. Fry
Christopher S. Fry
JLJonah D. Lee
Jonah D. Lee
EDEsther E. Dupont-Versteegden
Esther E. Dupont-Versteegden
Resident muscle stem cells, known as satellite cells, are thought to be the main mediators of skeletal muscle plasticity. Satellite cells are activated, replicate, and fuse into existing muscle fibers in response to both muscle injury and mechanical load. It is generally well-accepted that satellite cells participate in postnatal growth, hypertrophy, and muscle regeneration following injury; however, their role in muscle regrowth following an atrophic stimulus remains equivocal. The current study employed a genetic mouse model (Pax7-DTA) that allowed for the effective depletion of >90% of satellite cells in adult muscle upon the administration of tamoxifen. Vehicle and tamoxifen-treated young adult female mice were either hindlimb suspended for 14 days to induce muscle atrophy or hindlimb suspended for 14 days followed by 14 days of reloading to allow regrowth, or they remained ambulatory for the duration of the experimental protocol. Additionally, 5-bromo-2′-deoxyuridine (BrdU) was added to the drinking water to track cell proliferation. Soleus muscle atrophy, as measured by whole muscle wet weight, fiber cross-sectional area, and single-fiber width, occurred in response to suspension and did not differ between satellite cell-depleted and control muscles. Furthermore, the depletion of satellite cells did not attenuate muscle mass or force recovery during the 14-day reloading period, suggesting that satellite cells are not required for muscle regrowth. Myonuclear number was not altered during either the suspension or the reloading period in soleus muscle fibers from vehicle-treated or satellite cell-depleted animals. Thus, myonuclear domain size was reduced following suspension due to decreased cytoplasmic volume and was completely restored following reloading, independent of the presence of satellite cells. These results provide convincing evidence that satellite cells are not required for muscle regrowth following atrophy and that, instead, the myonuclear domain size changes as myofibers adapt.

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
EDEsther E Dupont-Versteegden
Esther E Dupont-Versteegden
Apoptosis in skeletal muscle and its relevance to atrophy

1 June 2008 in Experimental Gerontology
Verified
Journal Article
Closed access
Tim HoferTim Hofer
Tim Hofer
Emanuele MarzettiEmanuele Marzetti
Emanuele Marzetti
JXJinze Xu
Jinze Xu
ASArnold Y. Seo
Arnold Y. Seo
SGSukru Gulec
Sukru Gulec
EDEsther E. Dupont-Versteegden
Esther E. Dupont-Versteegden

1 January 2018 in Physiology
Verified
Journal Article
Closed access
PDF file
KMKevin A. Murach
Kevin A. Murach
CFChristopher S. Fry
Christopher S. Fry
TKTyler Kirby
Tyler Kirby
JJJanna R. Jackson
Janna R. Jackson
JLJonah D. Lee
Jonah D. Lee
CPCharlotte A. Peterson
Charlotte A. Peterson
Recent loss-of-function studies show that satellite cell depletion does not promote sarcopenia or unloading-induced atrophy, and does not prevent regrowth. Although overload-induced muscle fiber hypertrophy is normally associated with satellite cell-mediated myonuclear accretion, hypertrophic adaptation proceeds in the absence of satellite cells in fully grown adult mice, but not in young growing mice. Emerging evidence also indicates that satellite cells play an important role in remodeling the extracellular matrix during hypertrophy.

22 April 2020 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
DEDavis A. Englund
Davis A. Englund
KMKevin A. Murach
Kevin A. Murach
CDCory M. Dungan
Cory M. Dungan
VFVandré C. Figueiredo
Vandré C. Figueiredo
IVIvan J. Vechetti
Ivan J. Vechetti
CPCharlotte A. Peterson
Charlotte A. Peterson
To date, studies that have aimed to investigate the role of satellite cells during adult skeletal muscle adaptation and hypertrophy have utilized a nontranslational stimulus and/or have been performed over a relatively short time frame. Although it has been shown that satellite cell depletion throughout adulthood does not drive skeletal muscle loss in sedentary mice, it remains unknown how satellite cells participate in skeletal muscle adaptation to long-term physical activity. The current study was designed to determine whether reduced satellite cell content throughout adulthood would influence the transcriptome-wide response to physical activity and diminish the adaptive response of skeletal muscle. We administered vehicle or tamoxifen to adult Pax7-diphtheria toxin A (DTA) mice to deplete satellite cells and assigned them to sedentary or wheel-running conditions for 13 mo. Satellite cell depletion throughout adulthood reduced balance and coordination, overall running volume, and the size of muscle proprioceptors (spindle fibers). Furthermore, satellite cell participation was necessary for optimal muscle fiber hypertrophy but not adaptations in fiber type distribution in response to lifelong physical activity. Transcriptome-wide analysis of the plantaris and soleus revealed that satellite cell function is muscle type specific; satellite cell-dependent myonuclear accretion was apparent in oxidative muscles, whereas initiation of G protein-coupled receptor (GPCR) signaling in the glycolytic plantaris may require satellite cells to induce optimal adaptations to long-term physical activity. These findings suggest that satellite cells play a role in preserving physical function during aging and influence muscle adaptation during sustained periods of physical activity.